TriMedx company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - Fin | Alive



About TriMedx

TriMedx is a provider of clinical engineering services. Created by healthcare for healthcare, TriMedx understands that patients are the number one priority. Headquartered in Indianapolis, TriMedx started as a hospital clinical engineering department focusing on reducing expenses, optimizing service and enhancing the patient experience through innovative medical equipment management programs. Today, TriMedx is recognized around the globe as a leader in healthcare technology management.

TriMedx Headquarter Location

5451 Lakeview Parkway S Drive

Indianapolis, Indiana, 46268,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing TriMedx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TriMedx is included in 1 Expert Collection, including Conference Exhibitors.


Conference Exhibitors

5,302 items

Latest TriMedx News

TRIMEDX Develops New Cloud-Based Features to Boost Medical Device Cybersecurity

May 10, 2022

The Reallocation Platform leverages the firm’s RUDR Score to identify assets that can be “reallocated” to another site within a healthcare system. Michael Barbella, Managing Editor05.10.22 TRIMEDX  has crafted a new strategy to help healthcare systems reduce medical device cybersecurity risks, bolster patient safety, and optimize medical equipment across all sites of care. The company's new Reallocation Platform and a trio of medical device cybersecurity improvements further elevate how TRIMEDX partners with healthcare providers, which are faced with ongoing financial pressures, increased supply chain and labor expenses, the shifting of healthcare delivery to outpatient settings, and heightened cybersecurity risks. “A health system’s clinical assets account for more than 25 percent of its capital expenditures,” said TRIMEDX CEO Henry Hummel. “This is a significant financial resource that can be optimized to help organizations meet their financial objectives without compromising patient care or safety.”   Chief Marketing and Solutions Officer LeAnne Hester stated, “We are committed to ongoing solution enhancements that provide objective information and recommendations to healthcare executives within IT, finance, and operations that inform decisions across their continuum of care and support the implementation of their strategies.”   The Reallocation Platform is an integrated online system that leverages TRIMEDX’s proprietary RUDR Score to identify assets available for “reallocation” to another site within a healthcare system. Upon a healthcare system’s approval, medical devices with low utilization rates in their current sites are listed on the Reallocation Platform, where administrators at other sites within the same healthcare system can view, browse, and search for equipment that is needed at their facility. Leaders can compare devices on a host of attributes, such as make, model, manufacturer, age, and reliability, to find the equipment that best suits their needs. “The Reallocation Platform helps healthcare systems avoid unnecessary capital expenses associated with buying equipment for other sites of care that systemwide they don’t need,” said Dave Klumpe, TRIMEDX’s president of clinical asset management. “Plus, adding more equipment a system doesn’t need unnecessarily increases operational costs.”    Three new features within TRIMEDX’s Cyber Advanced solution will further enhance the company’s unmatched approach toward medical device cybersecurity. Ransomware attacks alone rose 123 percent in 2021, costing hospitals more than $21 billion. The Dynamic Risk Score helps in identifying where to prioritize efforts in addressing potential vulnerabilities in connected medical devices. The score updates based on a number of factors including leveraging TRIMEDX’s proprietary content library of existing cyber vulnerabilities and approved patches and the degree of risk to patient safety. As work is performed on a device or new information is available, the score will change to continually reassess work that should be prioritized across the entire device inventory. The Threats and Projects dashboard, supported by the Dynamic Risk Score, helps TRIMEDX CYBER specialists and their health system clients collaborate on and create projects. Projects can be used to prioritize vulnerabilities where healthcare providers can approve or reject compensating controls or accept the risk for a specific vulnerability. The Cyber Vulnerability Tracker provides a vulnerability profile that highlights key factors to know about a new or existing vulnerability in a health system’s clinical asset inventory. Factors include identifying all of the equipment associated with the vulnerability, what the status of each device is, and whether the device is mission critical. Armed with such information, health systems can better prioritize their risk mitigation and remediation efforts and ensure the most significant threats are addressed quickly. “Healthcare is targeted for cyberattacks more than any other industry, and as the use of connected medical devices continues to grow exponentially, the improvements in cybersecurity must keep up a similar pace,” said Doug Folsom, TRIMEDX chief technology officer and president of cybersecurity. “These tools help TRIMEDX and its client health systems identify and address vulnerabilities with added urgency.”    TRIMEDX is an independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity. The company helps healthcare providers transform their clinical assets into strategic tools, driving reductions in operational expenses, optimizing clinical asset capital spend, maximizing resources for patient care, and delivering improved safety and protection. TRIMEDX was built by providers, for providers, and leverages a history of expert clinical engineering with data on 92 percent of all active medical device models.

TriMedx Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

TriMedx Rank

  • When was TriMedx founded?

    TriMedx was founded in 1998.

  • Where is TriMedx's headquarters?

    TriMedx's headquarters is located at 5451 Lakeview Parkway S Drive, Indianapolis.

  • What is TriMedx's latest funding round?

    TriMedx's latest funding round is Acq - Fin.

  • Who are the investors of TriMedx?

    Investors of TriMedx include TowerBrook Capital Partners and Ascension Ventures.

  • Who are TriMedx's competitors?

    Competitors of TriMedx include Pentec Health, Shearwater Health, Trilogy Health Services, Upstream Rehabilitation, Capio, Paradigm, SCIO Health Analytics, Qliance Medical Management, Mytrus, Dr. Lal Path Labs and 31 more.

You May Also Like

MJ Group

MJ Group offers is a provider of healthcare check-up services

Achieve CCA Logo
Achieve CCA

Achieve CCA is a provider of debt management services to healthcare patients.


CorSolutions is a provider of outpatient cardiac and disease management services to patients and healthcare providers.

Paradigm Logo

Paradigm provides acute and ongoing catastrophic and complex case management services for traumatic brain injuries, spinal cord injuries, amputations, burns, wounds, and chronic pain. The company is a provider of complex and catastrophic medical management in the workers' compensation industry.

American Pathology Partners

American Pathology Partners is a network of pathology laboratories and practices dedicated to local and regional healthcare. Based on the individual needs of partner practices and laboratories, the company offers a wide array of world-class support services, including business support, access capital for liquidity and/or growth, and selected esoteric or subspecialty pathology services.


KCAS provides bioanalytical and biomarker testing for the pharma and biopharma industries.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.